Aadi Bioscience, Inc. (AADI)
Evaluation: Based on all recent filings, financial statements, and news.
See full evaluationAsk a question about Aadi Bioscience, Inc. (AADI)
Go deeper and ask any question about AADI
Company Performance
Current Price
as of Sep 13, 2024$1.80
P/E Ratio
N/A
Market Cap
$44.31M
Description
Aadi Bioscience, Inc. operates as a clinical-stage biopharmaceutical company. It develops precision therapies for genetically-defined cancer patients with mTOR pathway driver alterations such as alterations in TSC1 or TSC2 genes. The company was founded by Neil Desai in November 2007 and is headquartered in Los Angeles, CA.
Metrics
Overview
- HQLos Angeles, CA
- SectorHealth Technology
- IndustryBiotechnology
- TickerAADI
- Price$1.8+1.69%
Trading Information
- Market Cap$44.31M
- Float72.90%
- Average Daily Volume (1m)504,563
- Average Daily Volume (3m)299,934
- EPS-$2.43
Company
- Revenue$23.82M
- Rev Growth (1yr)-0.37%
- Net Income-$14.58M
- Gross Margin87.41%
- EBITDA Margin-251.40%
- EBITDA-$15.53M
- EV-$32.32M
- EV/Revenue-1.36
- P/EN/A
- P/S2.04
Documents
SEC Filings
Factset Street Account
Earnings Calls
Factset